ABDİ İBRAHİM
OTSUKA

Abdi İbrahim Otsuka was established in 2012 through a 50-50 partnership between Abdi İbrahim, Türkiye’s leading pharmaceutical company, and Otsuka Pharmaceutical, one of the oldest pharmaceutical companies in Japan. Abdi İbrahim Otsuka sources its strength from the mission and vision of these two large companies to add value to the Turkish market and those neighboring it. Abdi İbrahim Otsuka offers innovative approaches and treatment solutions, which are firsts and often the only ones in their respective field, for rare diseases such as CNS disorders, cardiovascular system diseases and the polycystic kidney disease with a view to improving the lives of patients and their relatives. The company aims to sit atop the competition among Japanese pharmaceutical companies in Türkiye and increase its contribution to Türkiye’s economy.

  • Foundation 2012
  • Head Office ISTANBUL
  • Number of Employees 70
  • Markets Türkiye, Singapore, Tunisia